Focus Stocks
Critical Alerts For Halliburton, Travelers, Express Scripts, HCA, and Human Genome Sciences Released By Seven Summits Research
Published on Tuesday, 07 February 2012 10:39 Written by TradersHuddle Staff
CHICAGO, Feb. 7, 2012 /PRNewswire/ -- Seven Summits Research issues critical PriceWatch Alerts for HAL, TRV, ESRX, HCA, and HGSI.
To see what our analysts have discovered about these stocks read the Seven Summits Strategic Investments' PriceWatch Alerts at http://www.iotogo.com/s/020712C (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover the following stocks: Halliburton (NYSE: HAL), Travelers (NYSE: TRV), Express Scripts (Nasdaq: ESRX), HCA Holdings (NYSE: HCA), and Human Genome Sciences (Nasdaq: HGSI).
In today's unsure markets these brief PriceWatch Alerts contain concise, detailed strategies for each covered stock and include position protection tactics designed to potentially defend investors from unexpected market shifts. While other market reports only provide stock news and opinion, we offer strategies that position investments against uncertainty and increase chances of making a profit, even if a stock goes down.
"Our PriceWatch Alerts go beyond other market reports. Along with a brief concise overview, each PriceWatch Alert provides useful strategies, which ensure potential investments are protected with basic hedging techniques," says Reid Stratton, Seven Summits Senior Analyst. "These brief company reports contain information that can benefit expert and novice investors who want to stay ahead of the market."
For essential information on stocks poised to move go to: http://www.iotogo.com/s/020712C for Seven Summits Strategic Investments' PriceWatch Alerts.
Seven Summits Investment Research is an independent investment research group, which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. For more information go to www.SevenSummitsInvestmentResearch.com. CRD# 137114
All stocks and options shown are examples only -- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes -- expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available at http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.
SOURCE Seven Summits Investment Research
Related Articles
- Halliburton to Present at the Citi Global Energy Conference
- New Ratings
- Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online
- Travelers: Time for the Bulls?
- HCA Announces National 2011 Frist Humanitarian Awards Recipients
- Six Years After Arriving in the U.S., Able to Speak Little English, Student Lands Position in Travelers’ Professional Development Program
- Poor Health Decisions Cost Billions; New Report Identifies Unhealthy Behavior as Top Concern of Benefit Providers
- Halliburton Annual Meeting of Stockholders and Dividend Declaration
- Dow's Top Performers :CSCO, MRK, TRV
- Halliburton to Present at the UBS Global Oil and Gas Conference
Related Partner Headlines
- Human Genome Sciences Inc (HGSI): Today's Featured Drugs Loser - TheStreet.com
- Halliburton Company (HAL): Today's Featured Basic Materials Winner - TheStreet.com
- GlaxoSmithKline Amends HGS Tender Offer to Address Poison Pill, Requires HGS to Redeem Pill - Benzinga
- Express Scripts (ESRX): Today's Featured Health Services Loser - TheStreet.com
- Benzinga's M&A Chatter for Thursday May 17, 2012 - Benzinga
- Human Genome Looks to Anyone but GlaxoSmithKline - Benzinga
- UPDATE: Citigroup Cuts PT to $60 on Express Scripts on Outlook Update - Benzinga
- Human Genome Sciences Board of Directors Unanimously Determines GlaxoSmithKline Unsolicited Tender Offer is Inadequate and Not in the Best Interests of Stockholders - Benzinga
- Human Genome Sciences Announces Adoption of Short-Term Stockholder Rights Plan - Benzinga
- Halliburton Company (HAL): Today's Featured Energy Loser - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Cramer's 'Mad Money' Recap: Big Government Not Protecting the Little Guys - TheStreet.com -
The Global Retrenchment Accelerates - TheStreet.com -
Bain Capital Sent 0,000-Plus to Obama and Dems in 2008 - TheStreet.com -
Market Preview: Low-Grade Uncertainty - TheStreet.com -
The EPA's Dangerous Game - TheStreet.com -
Sticking with the Preferred Plan - TheStreet.com -
Infoblox Posts Blowout Earnings; Shares Rise - TheStreet.com -
Salesforce.com Inc. (CRM): Today's Featured Computer Software & Services Loser - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
USFS, BLM Hire Youth for Public Lands Conservation Jobs -
SCVBank Elects Scott K. Rushing as New Chairman -
Heritage Oaks Bancorp to Pay Trust Preferred Interest and Accumulated TARP Dividends -
Law Office of Brodsky & Smith, LLC Announces Investigation of Ariba, Inc. -
Following Its Record 73% Jump FY 2011 Revenue, Privately-Held Milton Security Group Reports Repeat Double-Digit Sales Growth for First Quarter 2012 -
Diamond Value Management strategy and corporate turnaround leverages Rockwell repositioning -
Verizon Singapore Lauded for Its Sustainability Efforts -
Photo Release -- Cars For a Living: The World's First High-Octane Business Podcast









